{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:57:21Z","timestamp":1762102641412,"version":"3.37.3"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T00:00:00Z","timestamp":1621209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T00:00:00Z","timestamp":1621209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s00415-021-10610-w","type":"journal-article","created":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T17:03:00Z","timestamp":1621270980000},"page":"4388-4395","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Navigating migraine care through the COVID-19 pandemic: an update"],"prefix":"10.1007","volume":"268","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7004-3848","authenticated-orcid":false,"given":"Heather","family":"Angus-Leppan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelica E.","family":"Guiloff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Benson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto J.","family":"Guiloff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,17]]},"reference":[{"key":"10610_CR1","unstructured":"The Work Foundation. Migraine\u2019s impact on employment in Europe. https:\/\/www.lancaster.ac.uk\/work-foundation\/?wp-content\/uploads\/2018\/04\/Society%e2%80%99s-headache-the-socioeconomic-impact-of-migraine.-Work-Foundation.pdf. Accessed Nov 2020"},{"issue":"11","key":"10610_CR2","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/S1474-4422(18)30322-3","volume":"17","author":"Global Burden of Disease Headache Collaborators","year":"2018","unstructured":"Global Burden of Disease Headache Collaborators (2018) Global, regional, and national burden of migraine and tension-type headache, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17(11):954\u2013976. https:\/\/doi.org\/10.1016\/S1474-4422(18)30322-3","journal-title":"Lancet Neurol"},{"key":"10610_CR3","unstructured":"NHS England (2020) Improved NHS migraine care to save thousands of hospital stays. https:\/\/www.england.nhs.uk\/2020\/01\/improved-nhs-migraine-care\/. Accessed Dec 2020"},{"issue":"1","key":"10610_CR4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s10194-018-0946-z","volume":"19","author":"P Martelletti","year":"2018","unstructured":"Martelletti P, Schwedt TJ, Lanteri-Minet M et al (2018) My Migraine Voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed. J Headache Pain 19(1):115. https:\/\/doi.org\/10.1186\/s10194-018-0946-z","journal-title":"J Headache Pain"},{"key":"10610_CR5","unstructured":"World Health Organisation. Headache disorders. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/headache-disorders. Accessed Jan 2021"},{"key":"10610_CR6","unstructured":"World Health Organisation. Rapid assessment of service delivery for NCDs during the COVID-19 pandemic. https:\/\/www.who.int\/publications\/m\/item\/rapid-assessment-of-service-delivery-for-ncds-during-the-covid-19-pandemic. Accessed Mar 2021"},{"issue":"10","key":"10610_CR7","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1111\/head.13998","volume":"60","author":"H Bolay","year":"2020","unstructured":"Bolay H, Ozge A, Uluduz D et al (2020) Are migraine patients at increased risk for symptomatic coronavirus disease 2019 due to shared comorbidities? Headache 60(10):2508\u20132521. https:\/\/doi.org\/10.1111\/head.13998","journal-title":"Headache"},{"key":"10610_CR8","doi-asserted-by":"publisher","first-page":"m1985","DOI":"10.1136\/bmj.m1985","volume":"369","author":"AB Docherty","year":"2020","unstructured":"Docherty AB, Harrison EM, Green CA et al (2020) Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ 369:m1985. https:\/\/doi.org\/10.1136\/bmj.m1985","journal-title":"BMJ"},{"issue":"7821","key":"10610_CR9","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","volume":"584","author":"EJ Williamson","year":"2020","unstructured":"Williamson EJ, Walker AJ, Bhaskaran K et al (2020) Factors associated with COVID-19-related death using OpenSAFELY. Nature 584(7821):430\u2013436. https:\/\/doi.org\/10.1038\/s41586-020-2521-4","journal-title":"Nature"},{"issue":"7","key":"10610_CR10","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1046\/j.1468-2982.2003.00568.x","volume":"23","author":"TJ Steiner","year":"2003","unstructured":"Steiner TJ, Scher AI, Stewart WF et al (2003) The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity. Cephalalgia 23(7):519\u2013527. https:\/\/doi.org\/10.1046\/j.1468-2982.2003.00568.x","journal-title":"Cephalalgia"},{"issue":"19","key":"10610_CR11","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1212\/WNL.0000000000003919","volume":"88","author":"B Gelaye","year":"2017","unstructured":"Gelaye B, Sacco S, Brown WJ et al (2017) Body composition status and the risk of migraine: a meta-analysis. Neurology 88(19):1795\u20131804. https:\/\/doi.org\/10.1212\/WNL.0000000000003919","journal-title":"Neurology"},{"key":"10610_CR12","doi-asserted-by":"publisher","first-page":"i2610","DOI":"10.1136\/bmj.i2610","volume":"353","author":"T Kurth","year":"2016","unstructured":"Kurth T, Winter AC, Eliassen AH et al (2016) Migraine and risk of cardiovascular disease in women: prospective cohort study. BMJ 353:i2610. https:\/\/doi.org\/10.1136\/bmj.i2610","journal-title":"BMJ"},{"issue":"5","key":"10610_CR13","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1212\/01.wnl.0000252808.97649.21","volume":"68","author":"RB Lipton","year":"2007","unstructured":"Lipton RB, Bigal ME, Diamond M et al (2007) Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 68(5):343\u2013349. https:\/\/doi.org\/10.1212\/01.wnl.0000252808.97649.21","journal-title":"Neurology"},{"issue":"5","key":"10610_CR14","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1136\/practneurol-2012-000502","volume":"13","author":"H Angus-Leppan","year":"2013","unstructured":"Angus-Leppan H (2013) Migraine: mimics, borderlands and chameleons. Pract Neurol 13(5):308\u2013318. https:\/\/doi.org\/10.1136\/practneurol-2012-000502","journal-title":"Pract Neurol"},{"key":"10610_CR15","doi-asserted-by":"publisher","first-page":"k179","DOI":"10.1136\/bmj.k179","volume":"360","author":"H Angus-Leppan","year":"2018","unstructured":"Angus-Leppan H, Saatci D, Sutcliffe A et al (2018) Abdominal migraine. BMJ 360:k179. https:\/\/doi.org\/10.1136\/bmj.k179","journal-title":"BMJ"},{"issue":"6","key":"10610_CR16","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","volume":"77","author":"L Mao","year":"2020","unstructured":"Mao L, Jin H, Wang M et al (2020) Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 77(6):683\u2013690. https:\/\/doi.org\/10.1001\/jamaneurol.2020.1127","journal-title":"JAMA Neurol"},{"issue":"7","key":"10610_CR17","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/s41591-020-0916-2","volume":"26","author":"C Menni","year":"2020","unstructured":"Menni C, Valdes AM, Freidin MB et al (2020) Real-time tracking of self-reported symptoms to predict potential COVID-19. Nat Med 26(7):1037\u20131040. https:\/\/doi.org\/10.1038\/s41591-020-0916-2","journal-title":"Nat Med"},{"key":"10610_CR18","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3389\/fneur.2020.00565","volume":"11","author":"RT Pinzon","year":"2020","unstructured":"Pinzon RT, Wijaya VO, Buana RB et al (2020) Neurologic characteristics in coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. Front Neurol 11:565. https:\/\/doi.org\/10.3389\/fneur.2020.00565","journal-title":"Front Neurol"},{"key":"10610_CR19","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/978-1-4471-3787-0_23","volume-title":"Clinical trials in neurology","author":"H Angus-Leppan","year":"2001","unstructured":"Angus-Leppan H (2001) Headache: basic trial designs, sample sizes and pitfalls. In: Guiloff RJ (ed) Clinical trials in neurology. Springer, London, pp 279\u2013290"},{"key":"10610_CR20","doi-asserted-by":"publisher","first-page":"583870","DOI":"10.3389\/fneur.2020.583870","volume":"11","author":"A Planchuelo-Gomez","year":"2020","unstructured":"Planchuelo-Gomez A, Trigo J, de Luis-Garcia R et al (2020) Deep phenotyping of headache in hospitalized COVID-19 patients via principal component analysis. Front Neurol 11:583870. https:\/\/doi.org\/10.3389\/fneur.2020.583870","journal-title":"Front Neurol"},{"issue":"1","key":"10610_CR21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s10194-020-01188-1","volume":"21","author":"O Uygun","year":"2020","unstructured":"Uygun O, Ertas M, Ekizoglu E et al (2020) Headache characteristics in COVID-19 pandemic-a survey study. J Headache Pain 21(1):121. https:\/\/doi.org\/10.1186\/s10194-020-01188-1","journal-title":"J Headache Pain"},{"issue":"1","key":"10610_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s10194-020-01183-6","volume":"21","author":"JY Al-Hashel","year":"2020","unstructured":"Al-Hashel JY, Ismail II (2020) Impact of coronavirus disease 2019 (COVID-19) pandemic on patients with migraine: a web-based survey study. J Headache Pain 21(1):115. https:\/\/doi.org\/10.1186\/s10194-020-01183-6","journal-title":"J Headache Pain"},{"issue":"10","key":"10610_CR23","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1111\/head.13967","volume":"60","author":"JA Membrilla","year":"2020","unstructured":"Membrilla JA, de Lorenzo I, Sastre M et al (2020) Headache as a cardinal symptom of coronavirus disease 2019: a cross-sectional study. Headache 60(10):2176\u20132191. https:\/\/doi.org\/10.1111\/head.13967","journal-title":"Headache"},{"issue":"8","key":"10610_CR24","first-page":"1022","volume":"51","author":"RJ Guiloff","year":"1988","unstructured":"Guiloff RJ, Fruns M (1988) Limb pain in migraine and cluster headache. JNNP 51(8):1022\u20131031","journal-title":"JNNP"},{"key":"10610_CR25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/1756-0500-3-213","volume":"3","author":"A Liu","year":"2010","unstructured":"Liu A, Menon S, Colson NJ et al (2010) Analysis of the MTHFR C677T variant with migraine phenotypes. BMC Res Notes 3:213. https:\/\/doi.org\/10.1186\/1756-0500-3-213","journal-title":"BMC Res Notes"},{"issue":"1","key":"10610_CR26","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/head.14030","volume":"61","author":"M Smith","year":"2021","unstructured":"Smith M, Nakamoto M, Crocker J et al (2021) Early impact of the COVID-19 pandemic on outpatient migraine care in Hawaii: results of a quality improvement survey. Headache 61(1):149\u2013156. https:\/\/doi.org\/10.1111\/head.14030","journal-title":"Headache"},{"key":"10610_CR27","doi-asserted-by":"publisher","first-page":"m1557","DOI":"10.1136\/bmj.m1557","volume":"369","author":"M Douglas","year":"2020","unstructured":"Douglas M, Katikireddi SV, Taulbut M et al (2020) Mitigating the wider health effects of covid-19 pandemic response. BMJ 369:m1557. https:\/\/doi.org\/10.1136\/bmj.m1557","journal-title":"BMJ"},{"key":"10610_CR28","doi-asserted-by":"publisher","first-page":"563722","DOI":"10.3389\/fpsyg.2020.563722","volume":"11","author":"M Tommasi","year":"2020","unstructured":"Tommasi M, Toro F, Arno S et al (2020) Physical and psychological impact of the phase one lockdown for COVID-19 on Italians. Front Psychol 11:563722. https:\/\/doi.org\/10.3389\/fpsyg.2020.563722","journal-title":"Front Psychol"},{"key":"10610_CR29","doi-asserted-by":"publisher","DOI":"10.1177\/0333102420981739","author":"IE Verhagen","year":"2021","unstructured":"Verhagen IE, van Casteren DS, de Vries LS et al (2021) Effect of lockdown during COVID-19 on migraine: a longitudinal cohort study. Cephalagia. https:\/\/doi.org\/10.1177\/0333102420981739","journal-title":"Cephalagia"},{"key":"10610_CR30","doi-asserted-by":"publisher","first-page":"597881","DOI":"10.3389\/fneur.2020.597881","volume":"11","author":"M Delussi","year":"2020","unstructured":"Delussi M, Gentile E, Coppola G et al (2020) Investigating the effects of COVID-19 quarantine in migraine: an observational cross-sectional study from the Italian National Headache Registry (RICe). Front Neurol 11:597881. https:\/\/doi.org\/10.3389\/fneur.2020.597881","journal-title":"Front Neurol"},{"issue":"2","key":"10610_CR31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41582-020-00438-9","volume":"17","author":"V Patterson","year":"2021","unstructured":"Patterson V (2021) Neurological telemedicine in the COVID-19 era. Nat Rev Neurol 17(2):73\u201374. https:\/\/doi.org\/10.1038\/s41582-020-00438-9","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10610_CR32","doi-asserted-by":"publisher","first-page":"e23775","DOI":"10.2196\/23775","volume":"23","author":"HM James","year":"2021","unstructured":"James HM, Papoutsi C, Wherton J et al (2021) Spread, scale-up, and sustainability of video consulting in health care: systematic review and synthesis guided by the NASSS framework. J Med Internet Res 23(1):e23775. https:\/\/doi.org\/10.2196\/23775","journal-title":"J Med Internet Res"},{"issue":"3","key":"10610_CR33","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.pec.2020.12.027","volume":"104","author":"E Courtney","year":"2021","unstructured":"Courtney E, Blackburn D, Reuber M (2021) Neurologists\u2019 perceptions of utilising tele-neurology to practice remotely during the COVID-19 pandemic. Patient Educ Couns 104(3):452\u2013459. https:\/\/doi.org\/10.1016\/j.pec.2020.12.027","journal-title":"Patient Educ Couns"},{"key":"10610_CR34","doi-asserted-by":"publisher","unstructured":"Headache Classification Committee of the International Headache Society (IHS) (2018) The international classification of headache disorders, 3rd edn. In: Cephalalgia, vol 38, issue 1, pp 1\u2013211. doi: https:\/\/doi.org\/10.1177\/0333102417738202","DOI":"10.1177\/0333102417738202"},{"issue":"3","key":"10610_CR35","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1212\/WNL.0000000000006697","volume":"92","author":"TP Do","year":"2019","unstructured":"Do TP, Remmers A, Schytz HW et al (2019) Red and orange flags for secondary headaches in clinical practice: SNNOOP10 list. Neurology 92(3):134\u2013144. https:\/\/doi.org\/10.1212\/WNL.0000000000006697","journal-title":"Neurology"},{"issue":"4","key":"10610_CR36","doi-asserted-by":"publisher","first-page":"384","DOI":"10.7861\/clinmed.2020-0232","volume":"20","author":"BR Wakerley","year":"2020","unstructured":"Wakerley BR, Mollan SP, Sinclair AJ (2020) Idiopathic intracranial hypertension: update on diagnosis and management. Clin Med (Lond) 20(4):384\u2013388. https:\/\/doi.org\/10.7861\/clinmed.2020-0232","journal-title":"Clin Med (Lond)"},{"issue":"1","key":"10610_CR37","doi-asserted-by":"publisher","first-page":"e000487","DOI":"10.1136\/bmjophth-2020-000487","volume":"5","author":"K Safadi","year":"2020","unstructured":"Safadi K, Kruger JM, Chowers I et al (2020) Ophthalmology practice during the COVID-19 pandemic. BMJ Open Ophthalmol 5(1):e000487. https:\/\/doi.org\/10.1136\/bmjophth-2020-000487","journal-title":"BMJ Open Ophthalmol"},{"issue":"6","key":"10610_CR38","doi-asserted-by":"publisher","first-page":"407","DOI":"10.30773\/pi.2019.04.11","volume":"16","author":"YE Jang","year":"2019","unstructured":"Jang YE, Cho EY, Choi HY et al (2019) Diagnostic neuroimaging in headache patients: a systematic review and meta-analysis. Psychiatry Investig 16(6):407\u2013417. https:\/\/doi.org\/10.30773\/pi.2019.04.11","journal-title":"Psychiatry Investig"},{"key":"10610_CR39","unstructured":"Oxford Centre for evidence based medicine (2011). www.cebm.net\/ocebm-levels-of-evidence\/. Accessed Nov 2020"},{"key":"10610_CR40","unstructured":"NICE (2021) COVID-19 rapid evidence summary: acute use of non-steroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19. https:\/\/www.nice.org.uk\/advice\/es23\/chapter\/Key-messages. Accessed Jan 2021"},{"issue":"1","key":"10610_CR41","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s10194-020-01106-5","volume":"21","author":"A Maassen Van Den Brink","year":"2020","unstructured":"Maassen Van Den Brink A, de Vries T, Danser AHJ (2020) Headache medication and the COVID-19 pandemic. J Headache Pain 21(1):38. https:\/\/doi.org\/10.1186\/s10194-020-01106-5","journal-title":"J Headache Pain"},{"key":"10610_CR42","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00014-21","author":"JS Chen","year":"2021","unstructured":"Chen JS, Alfajaro MM, Chow RD et al (2021) Non-steroidal anti-inflammatory drugs dampen the cytokine and antibody response to SARS-CoV-2 infection. J Virol. https:\/\/doi.org\/10.1128\/JVI.00014-21","journal-title":"J Virol"},{"issue":"Suppl 1","key":"10610_CR43","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1526-4610.2012.02140.x","volume":"52","author":"SJ Tepper","year":"2012","unstructured":"Tepper SJ (2012) Opioids should not be used in migraine. Headache 52(Suppl 1):30\u201334. https:\/\/doi.org\/10.1111\/j.1526-4610.2012.02140.x","journal-title":"Headache"},{"issue":"10","key":"10610_CR44","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1111\/j.1532-5415.2011.03586.x","volume":"59","author":"S Dublin","year":"2011","unstructured":"Dublin S, Walker RL, Jackson ML et al (2011) Use of opioids or benzodiazepines and risk of pneumonia in older adults: a population-based case-control study. J Am Geriatr Soc 59(10):1899\u20131907. https:\/\/doi.org\/10.1111\/j.1532-5415.2011.03586.x","journal-title":"J Am Geriatr Soc"},{"key":"10610_CR45","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13256-016-0835-5","volume":"10","author":"L Canel","year":"2016","unstructured":"Canel L, Zisimopoulou S, Besson M et al (2016) Topiramate-induced severe heatstroke in an adult patient: a case report. J Med Case Rep 10:95. https:\/\/doi.org\/10.1186\/s13256-016-0835-5","journal-title":"J Med Case Rep"},{"key":"10610_CR46","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2021.1900092","author":"HS Tan","year":"2021","unstructured":"Tan HS, Frere Z, Krishnamoorthy V et al (2021) Association of gabapentinoid utilization with postoperative pulmonary complications in gynecologic surgery: a retrospective cohort study. Curr Med Res Opin. https:\/\/doi.org\/10.1080\/03007995.2021.1900092","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"10610_CR47","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/jgs.13932","volume":"64","author":"S Chatterjee","year":"2016","unstructured":"Chatterjee S, Carnahan RM, Chen H et al (2016) Anticholinergic medication use and risk of pneumonia in elderly adults: a nested case-control study. J Am Geriatr Soc 64(2):394\u2013400. https:\/\/doi.org\/10.1111\/jgs.13932","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"10610_CR48","doi-asserted-by":"publisher","first-page":"W25","DOI":"10.7326\/L20-1446","volume":"174","author":"K Mackey","year":"2021","unstructured":"Mackey K, Kansagara D, Vela K (2021) Update Alert 7: risks and impact of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers on SARS-CoV-2 infection in adults. Ann Intern Med 174(2):W25\u2013W29. https:\/\/doi.org\/10.7326\/L20-1446","journal-title":"Ann Intern Med"},{"issue":"3","key":"10610_CR49","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/ejhf.2060","volume":"23","author":"G Savarese","year":"2021","unstructured":"Savarese G, Benson L, Sundstrom J et al (2021) Association between renin-angiotensin-aldosterone system inhibitor use and COVID-19 hospitalization and death: a 1.4 million patient nationwide registry analysis. Eur J Heart Fail 23(3):476\u2013485. https:\/\/doi.org\/10.1002\/ejhf.2060","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10610_CR50","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1136\/practneurol-2015-001298","volume":"16","author":"S Miller","year":"2016","unstructured":"Miller S, Sinclair AJ, Davies B et al (2016) Neurostimulation in the treatment of primary headaches. Pract Neurol 16(5):362\u2013375. https:\/\/doi.org\/10.1136\/practneurol-2015-001298","journal-title":"Pract Neurol"},{"issue":"4S","key":"10610_CR51","first-page":"S311","volume":"23","author":"H Gharaei","year":"2020","unstructured":"Gharaei H, Diwan S (2020) COVID-19 pandemic: implications on interventional pain practice-a narrative review. Pain Physician 23(4S):S311\u2013S318","journal-title":"Pain Physician"},{"issue":"1","key":"10610_CR52","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s10194-017-0816-0","volume":"18","author":"A Negro","year":"2017","unstructured":"Negro A, Delaruelle Z, Ivanova TA et al (2017) Headache and pregnancy: a systematic review. J Headache Pain 18(1):106. https:\/\/doi.org\/10.1186\/s10194-017-0816-0","journal-title":"J Headache Pain"},{"key":"10610_CR53","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-020-04702-0","author":"C Lupi","year":"2020","unstructured":"Lupi C, Negro A, Gambassi E et al (2020) Medicines for headache before and during pregnancy: a retrospective cohort study (ATENA study). Neurol Sci. https:\/\/doi.org\/10.1007\/s10072-020-04702-0","journal-title":"Neurol Sci"},{"issue":"3","key":"10610_CR54","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1177\/2472555220975672","volume":"26","author":"I Naasani","year":"2021","unstructured":"Naasani I (2021) COMPARE analysis, a bioinformatic approach to accelerate drug repurposing against Covid-19 and other emerging epidemics. SLAS Discov 26(3):345\u2013351. https:\/\/doi.org\/10.1177\/2472555220975672","journal-title":"SLAS Discov"},{"key":"10610_CR55","doi-asserted-by":"publisher","first-page":"109891","DOI":"10.1016\/j.mehy.2020.109891","volume":"143","author":"G Unal","year":"2020","unstructured":"Unal G, Turan B, Balcioglu YH (2020) Immunopharmacological management of COVID-19: potential therapeutic role of valproic acid. Med Hypotheses 143:109891. https:\/\/doi.org\/10.1016\/j.mehy.2020.109891","journal-title":"Med Hypotheses"},{"key":"10610_CR56","doi-asserted-by":"publisher","first-page":"173988","DOI":"10.1016\/j.ejphar.2021.173988","volume":"898","author":"B Pitt","year":"2021","unstructured":"Pitt B, Sutton NR, Wang Z et al (2021) Potential repurposing of the HDAC inhibitor valproic acid for patients with COVID-19. Eur J Pharmacol 898:173988. https:\/\/doi.org\/10.1016\/j.ejphar.2021.173988","journal-title":"Eur J Pharmacol"},{"issue":"2 & 3","key":"10610_CR57","doi-asserted-by":"publisher","first-page":"160","DOI":"10.4103\/ijmr.IJMR_585_20","volume":"151","author":"SS Cherian","year":"2020","unstructured":"Cherian SS, Agrawal M, Basu A et al (2020) Perspectives for repurposing drugs for the coronavirus disease 2019. Indian J Med Res 151(2 & 3):160\u2013171. https:\/\/doi.org\/10.4103\/ijmr.IJMR_585_20","journal-title":"Indian J Med Res"},{"issue":"3","key":"10610_CR58","doi-asserted-by":"publisher","first-page":"C279","DOI":"10.1152\/ajpcell.00478.2020","volume":"30","author":"S Krishnamurthy","year":"1993","unstructured":"Krishnamurthy S, Lockey RF, Kolliputi N (2021) Soluble ACE2 as a potential therapy for COVID-19. Am J Physiol Cell Physiol 320(3):C279\u2013C281. https:\/\/doi.org\/10.1152\/ajpcell.00478.2020","journal-title":"Am J Physiol Cell Physiol"},{"issue":"8","key":"10610_CR59","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nm1267","volume":"11","author":"K Kuba","year":"2005","unstructured":"Kuba K, Imai Y, Rao S et al (2005) A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med 11(8):875\u2013879. https:\/\/doi.org\/10.1038\/nm1267","journal-title":"Nat Med"},{"issue":"12","key":"10610_CR60","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1161\/CIRCRESAHA.120.317174","volume":"126","author":"VL Murthy","year":"2020","unstructured":"Murthy VL, Koupenova M, Shah RV (2020) ACEing COVID-19: a role for angiotensin axis inhibition in SARS-CoV-2 infection? Circ Res 126(12):1682\u20131684. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.317174","journal-title":"Circ Res"},{"key":"10610_CR61","doi-asserted-by":"publisher","first-page":"100042","DOI":"10.1016\/j.medidd.2020.100042","volume":"6","author":"M Kandasamy","year":"2020","unstructured":"Kandasamy M (2020) Perspectives for the use of therapeutic Botulinum toxin as a multifaceted candidate drug to attenuate COVID-19. Med Drug Discov 6:100042. https:\/\/doi.org\/10.1016\/j.medidd.2020.100042","journal-title":"Med Drug Discov"},{"key":"10610_CR62","unstructured":"World Health Organisation. WHO Living guideline: Drugs to prevent COVID-19 [January 2021]."},{"key":"10610_CR63","doi-asserted-by":"publisher","DOI":"10.1111\/head.14086","author":"AA Gelfand","year":"2021","unstructured":"Gelfand AA, Poland G (2021) Migraine treatment and COVID-19 vaccines: no cause for concern. Headache. https:\/\/doi.org\/10.1111\/head.14086","journal-title":"Headache"},{"issue":"2","key":"10610_CR64","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/head.14056","volume":"61","author":"TJ Schwedt","year":"2021","unstructured":"Schwedt TJ, Hentz JG, Sahai-Srivastava S et al (2021) Headache characteristics and burden from chronic migraine with medication overuse headache: cross-sectional observations from the medication overuse treatment strategy trial. Headache 61(2):351\u2013362. https:\/\/doi.org\/10.1111\/head.14056","journal-title":"Headache"},{"issue":"5","key":"10610_CR65","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.nrl.2020.05.004","volume":"35","author":"S Santos-Lasaosa","year":"2020","unstructured":"Santos-Lasaosa S, Porta-Etessam J (2020) OnabotulinumtoxinA infiltration and nerve blocks in patients with headache and neuralgia: safety recommendations to prevent SARS-CoV-2 infection. Neurologia 35(5):291\u2013294. https:\/\/doi.org\/10.1016\/j.nrl.2020.05.004","journal-title":"Neurologia"},{"issue":"7","key":"10610_CR66","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1111\/head.13880","volume":"60","author":"J Porta-Etessam","year":"2020","unstructured":"Porta-Etessam J, Gonzalez-Garcia N, Matias-Guiu JA et al (2020) Should we adapt the prescription criteria for specific treatments for migraine due to the COVID-19 pandemic? Headache 60(7):1448\u20131449. https:\/\/doi.org\/10.1111\/head.13880","journal-title":"Headache"},{"issue":"13","key":"10610_CR67","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1177\/0333102420965157","volume":"40","author":"E Caronna","year":"2020","unstructured":"Caronna E, Ballve A, Llaurado A et al (2020) Headache: a striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution. Cephalalgia 40(13):1410\u20131421. https:\/\/doi.org\/10.1177\/0333102420965157","journal-title":"Cephalalgia"},{"key":"10610_CR68","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-266574\/v1","author":"S Lopez-Leon","year":"2021","unstructured":"Lopez-Leon S, Wegman-Ostrosky T, Perelman C et al (2021) More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Res Sq. https:\/\/doi.org\/10.21203\/rs.3.rs-266574\/v1","journal-title":"Res Sq"},{"issue":"13","key":"10610_CR69","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1177\/0333102420965132","volume":"40","author":"TD Rozen","year":"2020","unstructured":"Rozen TD (2020) Daily persistent headache after a viral illness during a worldwide pandemic may not be a new occurrence: lessons from the 1890 Russian\/Asiatic flu. Cephalalgia 40(13):1406\u20131409. https:\/\/doi.org\/10.1177\/0333102420965132","journal-title":"Cephalalgia"},{"key":"10610_CR70","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1471-2377-11-30","volume":"11","author":"MK Ravindran","year":"2011","unstructured":"Ravindran MK, Zheng Y, Timbol C et al (2011) Migraine headaches in chronic fatigue syndrome (CFS): comparison of two prospective cross-sectional studies. BMC Neurol 11:30. https:\/\/doi.org\/10.1186\/1471-2377-11-30","journal-title":"BMC Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10610-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-021-10610-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10610-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T15:44:05Z","timestamp":1633967045000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-021-10610-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,17]]},"references-count":70,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["10610"],"URL":"https:\/\/doi.org\/10.1007\/s00415-021-10610-w","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"type":"print","value":"0340-5354"},{"type":"electronic","value":"1432-1459"}],"subject":[],"published":{"date-parts":[[2021,5,17]]},"assertion":[{"value":"2 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"HAL reports research support from National Institute for Health Research (NIHR), Epilepsy Action and Royal Free Charity, and Honoraria from Eisai, Sanofi and UCB unrelated to this work. AG KB and RJG have nothing to report. None of us have been involved in, or paid for, any CGRP-antagonist related work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"None required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}